QUESTA SCHEDA CONTIENE INFORMAZIONI CHE POSSONO GENERARE SITUAZIONI DI PERICOLO E DANNI. I DATI PRESENTI HANNO SOLO UN FINE ILLUSTRATIVO E IN NESSUN CASO ESORTATIVO. PRIMA DI PROSEGUIRE SI PREGA DI LEGGERE ATTENTAMENTE LE AVVERTENZE.AVVERTENZE:Tutte le informazioni, voci e documenti riportati su Shamanism&Co sono da considerare ad ESCLUSIVO SCOPO DIVULGATIVO!
Le eventuali nozioni e/o procedure mediche, erboristiche di medicina popolare, ecc. NON POSSONO SOSTITUIRE IN ALCUN CASO IL CONSIGLIO DEL MEDICO o di qualunque altro operatore sanitario. Rivolgetevi sempre al vostro medico o altro addetto del settore sanitario per qualsiasi quesito possiate avere.
Shamanism&Co non può esser ritenuto responsabile dei risultati o delle conseguenze di un qualsiasi utilizzo o tentativo di utilizzo di una qualsiasi delle informazioni pubblicate.
E' un ottimo immunostimolante; usata sin dall'antichità dai Indiani Nativi Americani
per le sue qualità medicinali, ad esempio come analgesico, per i dolori alla gola e alla testa.FONTE:
Da Wikipedia, l'enciclopedia libera.
Echinacea Moench, 1794 è un genere di piante erbacee perenni della famiglia delle Asteraceae, originarie del Nord America, comprendente nove specie d'interesse ornamentale ed erboristico.
Linneo battezzò questo genere Rudbeckia in omaggio a O. Rudbeck, botanico svedese del XVII sec. Il genere fu poi rinominato da Moench, nel 1794, Echinacea (dal greco echinos, riccio), secondo alcuni autori per la struttura dei semi che possiedono, alla loro sommità, un margine con 4 denti appuntiti; secondo altri, per le brattee pungenti del capolino.
Distribuzione e habitat
Le Echinacee sono originarie del Nord America, presentano un areale molto esteso che va dalle zone costiere del Golfo del Messico alle Grandi Pianure (Great Plains), fino al Lago Grande a Nord, alle montagne Rocciose ad Ovest ed alla catena degli Appalachi ad Est, interessando numerosi stati. Le Echinacee mostrano una notevole adattabilità alle diverse condizioni ambientali; crescono spontaneamente sia nelle zone di pianura che ad alta quota (fino ad oltre 1500 m di altitudine), privilegiando aree aperte e soleggiate, senza esigenze particolari di terreno anche se prediligono suoli moderatamente fertili, ben drenati e tendenti al sabbioso, come quelli delle grandi praterie nordamericane.
Le Echinacee sono piante erbacee poliennali con riposo vegetativo invernale (la parte epigea si dissecca in autunno), appaiono dalla primavera inoltrata all’autunno e fioriscono tra giugno e agosto. L’apparato radicale è più o meno fascicolato, con radici singole di calibro differente; le foglie, riunite in rosette basali e poi distribuite lungo gli scapi, sono lanceolate od ellittiche, con margine intero o seghettato e generalmente provviste di peli. Il fusto, di altezza variabile da 50 a 150 cm, ha un portamento eretto, si presenta più o meno peloso, ramificato e rivestito di poche o molte foglie, a seconda della specie. Il capolino è terminale, lungamente peduncolato, con ricettacolo conico, fiori ligulati (sterili) di lunghezza e tonalità variabili dal bianco-rosato al rosa-purpureo, e fiori tubulosi (fertili) ermafroditi; il polline può presentare diverse colorazioni. Il frutto è un achenio quadrangolare con presenza od assenza di pigmentazione marrone chiaro all’apice e fornito di un piccolo pappo.
In passato vi era molta confusione sulla nomenclatura del genere e delle varie specie: fino a tempi recenti, infatti, queste sono state largamente confuse tra loro nelle caratteristiche e nelle proprietà, a causa anche di forti somiglianze morfologiche. Solo da poco, attraverso moderni metodi analitici, si è pervenuti alla loro differenziazione filogenetica su basi biochimiche.[senza fonte]
Le informazioni qui riportate hanno solo un fine illustrativo: non costituiscono e non provengono né da prescrizione né da consiglio medico. Wikipedia non dà consigli medici: leggi le avvertenze.
L'uso medicinale di questa pianta si perde nei tempi: gli Amerindi del Nord America usavano il rizoma per curare piaghe e affezioni varie della pelle, ferite da traumi e da morsi dei serpenti. Per uso esterno, il rizoma delle echinacee ha in effetti proprietà cicatrizzanti, antiinfettive e riepitelizzanti.
La farmacopea moderna ha esteso le conoscenze popolari attribuendo a queste piante un ruolo in primo piano nel rafforzamento delle difese immunitarie. Oltre agli usi esterni per scopi medicamentosi o fitocosmetici, l'echinacea può essere usata anche per la cura delle affezioni influenzali e del raffreddore. L'Agenzia europea per i medicinali (EMEA) ha approvato l'uso di estratto di fiori di Echinacea purpurea per la prevenzione a breve termine ed il trattamento del raffreddore. Secondo le raccomandazioni dell'agenzia:
Non dovrebbe essere assunto per più di 10 giorni. La somministrazione a bambini di età inferiore ad 1 anno è controindicata, a causa di possibili effetti indesiderati su di un sistema immunitario immaturo. L'uso per bambini tra gli 1 e i 12 anni di età è sconsigliato, in quanto l'efficacia non è stata sufficientemente documentata sebbene nemmeno rischi specifici siano stati documentati. In assenza di dati sufficienti, è sconsigliato l'uso durante la gravidanza e l'allattamento.
In fitocosmesi, per le sue proprietà, l'echinacea è utile come decongestionante e purificante delle pelli, per il trattamento delle rughe, dell'acne, delle smagliature, delle screpolature.
Le indiscusse proprietà attribuite dalla farmacopea moderna rendono questo genere di grande interesse nel settore farmaceutico ed erboristico. Sono piante abbastanza rustiche e si prestano alla coltivazione per scopi industriali. In Italia si adatta abbastanza bene per colture a ciclo primaverile estivo. La specie di maggior interesse come pianta medicinale è l'Echinacea purpurea, ma sono largamente oggetto di commercio e di moltiplicazione anche l'Echinacea angustifolia e l'Echinacea pallida.
Le echinacee sono interessanti anche come piante ornamentali, per la grandezza e la vistosità dei capolini.
La tradizione popolare attribuisce proprietà afrodisiache che però non trovano riscontro nella documentazione scientifica.
^ Human Medicines - Herbal Medicinal Products
^ Monografia dell'EMEA sull' Echinacea purpurea
Douglas Schar, Echinacea. La pianta che stimola le difese immunitarie, Tecniche Nuove, 2000. ISBN 978-88-481-1066-2
Attribution: Andrew Butko
FONTE IMMAGINE: http://commons.wikimedia.org/wiki/File:Ab_plant_03.jpgFONTE:
From Wikipedia, the free encyclopedia
Echinacea (play /ˌɛkɨˈneɪʃⁱə/) is a genus of herbaceous flowering plants in the daisy family, Asteraceae. The nine species it contains are commonly called purple coneflowers. They are endemic to eastern and central North America, where they are found growing in moist to dry prairies and open wooded areas. They have large, showy heads of composite flowers, blooming from early to late summer. The generic name is derived from the Greek word ἐχῖνος (echino), meaning "sea urchin," due to the spiny central disk. Some species are used in herbal medicines and some are cultivated in gardens for their showy flowers. A few species are of conservation concern.
FONTE IMMAGINE: http://en.wikipedia.org/wiki/File:EchinaceaPurpureaMaxima1a.UME.JPG
Echinacea species are herbaceous, drought-tolerant perennial plants growing up to 140 cm in height. They grow from taproots, except E. purpurea, which grows from a short caudex with fibrous roots. They have erect stems that in most species are unbranched. Both the basal and cauline leaves are arranged alternately. The leaves are normally hairy with a rough texture, having uniseriate trichomes (1-4 rings of cells) but sometimes they lack hairs. The basal leaves and the lower stem leaves have petioles, and as the leaves progress up the stem the petioles often decrease in length. The leaf blades in different species may have one, three or five nerves. Some species have linear to lanceolate shaped leaves, and others have elliptic- to ovate-shaped leaves; often the leaves decrease in size as they progress up the stems. Leaf bases gradually increase in width away from the petioles or the bases are rounded to heart shaped. Most species have leaf margins that are entire, but sometimes they are dentate or serrate. The flowers are collected together into single rounded heads that terminate long peduncles. The inflorescences have crateriform to hemispheric shaped involucres which are 12–40 mm wide. The phyllaries, or bracts below the flower head, are persistent and number 15–50. The phyllaries are produced in a 2–4 series. The receptacles are hemispheric to conic in shape. The paleae have orange to reddish purple ends, and are longer than the disc corollas. The paleae bases partially surrounding the cypselae, and are keeled with the apices abruptly constricted to awn-like tips. The ray florets number 8–21 and the corollas are dark purple to pale pink, white, or yellow. The tubes of the corolla are hairless or sparsely hairy, and the laminae are spreading, reflexed, or drooping in habit and linear to elliptic or obovate in shape. The abaxial faces of the laminae are glabrous or moderately hairy. The flower heads have typically 200-300 fertile, bisexual disc florets but some have more. The corollas are pinkish, greenish, reddish-purple or yellow and have tubes shorter than the throats. The pollen is normally yellow in most species, but usually white in E. pallida. The three or four-angled fruits, called cypselae, are tan or bicolored with a dark brown band distally. The pappi is persistent and variously crown-shaped with 0 to 4 or more prominent teeth. x = 11.
Like all Asteraceae, the flowering structure is a composite inflorescence, with purple (rarely yellow or white) florets arranged in a prominent, somewhat cone-shaped head – "cone-shaped" because the petals of the outer ray florets tend to point downward (are reflexed) once the flower head opens, thus forming a cone. Plants are generally long lived, with distinctive flowers. The common name "cone flower" comes from the characteristic center “cone” at the center of the flower. The generic name Echinacea is rooted in the Greek word ἐχῖνος (echinos), meaning sea urchin, it references the spiky appearance and feel of the flower heads. Echinacea plants also reseed in the fall. New flowers will grow where seeds have fallen from the prior year.
FONTE IMMAGINE: http://en.wikipedia.org/wiki/File:Echinacea_3.jpg
The species of Echinacea are
Echinacea angustifolia – Narrow-leaf Coneflower
Echinacea atrorubens – Topeka Purple Coneflower
Echinacea laevigata – Smooth Coneflower, Smooth Purple Coneflower
Echinacea pallida – Pale Purple Coneflower
Echinacea paradoxa – Yellow Coneflower, Bush's Purple Coneflower
Echinacea purpurea – Purple Coneflower, Eastern Purple Coneflower
Echinacea sanguinea – Sanguine purple Coneflower
Echinacea simulata – Wavyleaf Purple Coneflower
Echinacea tennesseensis – Tennessee Coneflower
Researchers at the Agricultural Research Service are using DNA analysis to help determine the number of Echinacea species. The DNA analysis allows researchers to reveal clear distinctions among species based on chemical differences in root metabolites. The research concluded that of the 40 genetically diverse populations of Echinacea studied, there were nine distinct species. 
Marketed and studied medicinal products contain different species (E. purpurea, E. angustifolia, E. pallida), different organs (roots and herbs) and different preparations (extracts and expressed juice). Their chemical compositions are very different.
Multiple scientific reviews and meta-analyses have evaluated the published peer reviewed literature on the immunological effects of Echinacea. Reviews of the medicinal effects of Echinacea are often complicated by the inclusion of these different products. Evaluation of the literature within the field suffers generally from a lack of well-controlled trials, with many studies of low quality.
A 2007 study by the University of Connecticut combined findings from 14 previously reported trials examining Echinacea and concluded that Echinacea can cut the chances of catching a cold by more than half, and shorten the duration of a cold by an average of 1.4 days. However, Dr. Wallace Sampson, an editor of Scientific Review of Alternative Medicine and a Stanford University emeritus clinical professor of medicine, says that the referenced trials lack the similarities necessary to provide definitive results when combined into one report. "If you have studies that measure different things, there is no way to correct for that. These researchers tried, but you just can’t do it."
A 2003 controlled double-blind study from the University of Virginia School of Medicine and documented in the New England Journal of Medicine stated that echinacea extracts had "no clinically significant effects" on rates of infection or duration or intensity of symptoms. The effects held when the herb was taken immediately following infectious viral exposure and when taken as a prophylaxis starting a week prior to exposure. In a press release, Dr. Michael Murray, the Director of Education for Factors Group of Nutritional Companies, a manufacturer of Echinacea-related products, calls the study "faulty and inaccurate." According to Dr. Murray, none of the three extracts used on the 399 study participants contained all three of the components of Echinacea responsible for its immune-enhancing effects: polysaccharides, alkylamides and cichoric acid. In addition, Dr. Murray said "the standard dosage for dried Echinacea angustifolia root is normally three grams per day or more and this study used less than one gram."
An earlier University of Maryland review based on 13 European studies concluded that echinacea, when taken at first sign of a cold, reduced cold symptoms or shortened their duration. The review also found that three of four published studies concluded that taking echinacea to prevent a cold was ineffective.
The European Medicines Agency (EMEA) assessed the body of evidence and approved the use of expressed juice and dried expressed juice from fresh flowering aerial parts of Echinacea purpurea for the short-term prevention and treatment of the common cold. According to their recommendations:
It should not be used for more than 10 days. The use in children below 1 year of age is contraindicated, because of theoretically possible undesirable effect on immature immune system. The use in children between 1 and 12 years of age is not recommended, because efficacy has not been sufficiently documented although specific risks are not documented. In the absence of sufficient data, the use in pregnancy and lactation is not recommended.
Popular belief and traditional use
Echinacea is popularly believed to be an immunostimulator, stimulating the body's non-specific immune system and warding off infections and also being utilized as a laxative. A study commonly used to support that belief is a 2007 meta-analysis in The Lancet Infectious Diseases. The studies pooled in the meta-analysis used different types of echinacea, different parts of the plant, and various dosages. This review cannot inform recommendations on the efficacy of any particular type of echinacea, dosage, or treatment regimen. The safety of echinacea under long-term use is also unknown.
Echinacea angustifolia was widely used by the North American Plains Indians for its general medicinal qualities. Echinacea was one of the basic antimicrobial herbs of eclectic medicine from the mid 19th century through the early 20th century, and its use was documented for snakebite, anthrax, and for relief of pain. In the 1930s echinacea became popular in both Europe and America as a herbal medicine. According to Wallace Sampson, MD, its modern day use as a treatment for the common cold began when a Swiss herbal supplement maker was "erroneously told" that echinacea was used for cold prevention by Native American tribes who lived in the area of South Dakota. Although Native American tribes didn't use echinacea to prevent the common cold, some Plains tribes did use echinacea to treat some of the symptoms that could be caused by the common cold: The Kiowa used it for coughs and sore throats, the Cheyenne for sore throats, the Pawnee for headaches, and many tribes including the Lakotah used it as an analgesic.
Native Americans learned of E. angustifolia by observing elk seeking out the plants and consuming them when sick or wounded, and identified those plants as elk root.
Like most crude drugs from plant or animal origin, the constituent base for echinacea is complex, consisting of a wide variety of chemicals of variable effect and potency. Some chemicals may be directly antimicrobial, while others may work at stimulating or modulating different parts of the immune system. All species have chemical compounds called phenols, which are common to many other plants. Both the phenol compounds cichoric acid and caftaric acid are present in E. purpurea, other phenols include echinacoside, which is found in greater levels within E. angustifolia and E. pallida roots than in other species. When making herbal remedies, these phenols can serve as markers for the quantity of raw echinacea in the product. Other chemical constituents that may be important in echinacea health effects include alkylamides and polysaccharides.
The immunomodulatory effects of echinacea preparations are likely caused by fat-soluble alkylamides (alkamides), which occur mostly in E. angustifolia and E. purpurea but not in E. pallida. Alkylamides bind to human CB2 and CB1 cannabinoid receptors and thus inhibit tumor necrosis factor α TNF-alpha. These Alkylamides have similar potency to that of THC at the CB2 receptor, with THC being around 1.5 times stronger (~40 nm vs ~60 nm affinities). However, potency is dramatically less than that of THC at the psychoactive CB1 receptor (~40 nm vs ~ >1500 nm affinities).
As with any herbal preparation, individual doses may vary significantly in active chemical composition. In addition to poor process control which may affect inter- and intra-batch homogeneity, species, plant part, extraction method, and contamination or adulteration with other products all lead to variability between products.
Root or whole plant
As with any plant, the chemical makeup of echinacea is not consistent throughout the organism. In particular, the root has been promoted as containing a more efficacious mixture of active chemicals. A 2003 study in the Journal of the American Medical Association (Taylor et al. 2003) found that when echinacea products made from the entire plant were taken after the second cold symptom appeared they provided no measurable beneficial effect for children in treating the severity or duration of symptoms caused by the common cold virus. A 2005 study in the New England Journal of Medicine (Turner, 2005) focused on several root extracts, but still found no statistically significant effects on duration, intensity, or prevention of symptoms.
Frequency of administration
Proponents of echinacea assert that it is not a "one-dose" treatment, and that in order to work effectively, a dose should be taken at the very first sign of a cold symptom. Subsequent doses are called for every two to four hours after the first dose, including during the overnight sleeping period, until the cold symptoms have disappeared.
The several species of echinacea differ in their precise chemical constitution, and may provide variable dosages of any active ingredients.
FONTE IMMAGINE: http://commons.wikimedia.org/wiki/File:Echinacea_2007.JPG
Side effects and contraindications
When taken by mouth, Echinacea does not usually cause side effects. One of the most extensive and systematic studies to review the safety of Echinacea products concluded that overall, "adverse events are rare, mild and reversible," with the most common symptoms being "gastrointestinal and skin-related." Such side effects include nausea, abdominal pain, diarrhea, itch, and rash. Echinacea has also been linked to rare allergic reactions, including asthma, shortness of breath, and one case of anaphylaxis.. Muscle and joint pain has been associated with Echinacea, but it may have been caused by cold or flu symptoms for which the Echinacea products were administered. There are isolated case reports of rare and idiosyncratic reactions including thrombocytopenic purpura, leucopenia, hepatitis, renal failure, and atrial fibrillation, although it is not clear that these were due to Echinacea itself.
There are concerns that by stimulating immune function, Echinacea could potentially exacerbate autoimmune disease and/or decrease the effectiveness of immunosuppresive drugs, but this warning is based on theoretical considerations rather than human data. There have been no case reports of any drug interactions with Echinacea and "the currently available evidence suggests that echinacea is unlikely to pose serious health threats for patients combining it with conventional drugs."
As a matter of manufacturing safety, one investigation by an independent consumer testing laboratory found that five of eleven selected retail Echinacea products failed quality testing. Four of the failing products contained levels of phenols below the potency level stated on the labels. One failing product was contaminated with lead.
Some species of echinacea, notably E. purpurea, E. angustifolia, and E. pallida, are grown as ornamental plants in gardens. They tolerate a wide variety of conditions, maintain attractive foliage throughout the season, and multiply rapidly. Appropriate species are used in prairie restorations.
Ecinacea extracts inhibited growth of three species of trypanosomatids: Leishmania donovani, Leishmania major, and Trypanosoma brucei.
^ Sunset Western Garden Book, 1995:606–607
^ "Echinacea in Flora of North America @". Efloras.org. Retrieved 2010-02-01.
^ Plowden, Celeste. A manual of plant names. London, Allen and Unwin, 1972.. p. 47. ISBN 0-04-580008-1.
^ Organic Botanics
^ Barnes J, Anderson LA, Gibbons S, Phillipson JD. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2005 Aug;57(
^ Laasonen M, Wennberg T, Harmia-Pulkkinen T, Vuorela H. Simultaneous analysis of alkamides and caffeic acid derivatives for the identification of Echinacea purpurea, Echinacea angustifolia, Echinacea pallida and Parthenium integrifolium roots. Planta Med. 2002 Jun;68(6):572-4.
^ a b Hart A, Dey P (2009). "Echinacea for prevention of the common cold: an illustrative overview of how information from different systematic reviews is summarised on the internet". Preventive Medicine 49 (2–3): 78–82. doi:10.1016/j.ypmed.2009.04.006. PMID 19389422.
^ a b c Sachin A Shah, Stephen Sander, C Michael White, Mike Rinaldi, Craig I Coleman (July 2007). "Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis". The Lancet Infectious Diseases 7 (7): 473–480. doi:10.1016/S1473-3099(07)70160-3. ISSN 1473-3099. PMID 17597571.
^ Woelkart K, Linde K, Bauer R (May 2008). "Echinacea for preventing and treating the common cold". Planta Medica 74 (6): 633–7. doi:10.1055/s-2007-993766. PMID 18186015.
^ Linde K, Barrett B, Wölkart K, Bauer R, Melchart D (2006). Linde, Klaus. ed. "Echinacea for preventing and treating the common cold". Cochrane Database of Systematic Reviews (Online) (1): CD000530. doi:10.1002/14651858.CD000530.pub2. PMID 16437427.
^ "Echinacea may halve the risk of catching cold". New Scientist. Retrieved 1 May 2010.
^ a b Study: Echinacea Cuts Colds by Half WebMD Health News, June 26, 2007
^ a b Turner, Ronald B.; Rudolf Bauer, Karin Woelkart, Thomas C. Hulsey, and J. David Gangemi (28 July 2005). "An Evaluation of Echinacea angustifolia in Experimental Rhinovirus Infections". The New England Journal of Medicine 353 (4): 341–348. doi:10.1056/NEJMoa044441. ISSN 0028-4793. PMID 16049208.
^ New Study on Echinacea is Faulty, says Canadian-Based Company Medical News Today, August 15, 2005
^ Paul Bergner. "Healing Power of Echinacea and Goldenseal and Other Immune System Herbs" (The Healing Power)1997
^ "Human Medicines – Herbal Medicinal Products". Emea.europa.eu. 2009-04-03. Retrieved 2010-02-01.
^ "Community Herbal Monograph on Echinacea Purpurea". European Medicines Agency. 8 May 2008. Retrieved 2010-06-20.
^ Caruso TJ, Gwaltney JM (Mar 2005). "Treatment of the common cold with echinacea: a structured review". Clin. Infect. Dis. 40 (6): 807–10. doi:10.1086/428061. ISSN 1058-4838. PMID 15736012.
^ Wishart, David J. (2007). Encyclopedia of the Great Plains Indians. U of Nebraska Press. p. 156. ISBN 9780803298620.
^ Moerman, Daniel E. (1998). Native American Ethnobotany. Timber Press. p. 205. ISBN 9780881924534.
^ Edible and Medicinal Plants of the West, Gregory L. Tilford, ISBN 0-87842-359-1
^ Wichtl Max (Ed.) 2004. Herbal Drugs and Phytopharmaceuticals. medpharm Scientific Publishers/CRC Press. pp 179–186. ISBN 0-8493-1961-7
^ Gertsch Jürg et al. (2004). “Alkylamides from Echinacea are a New Class of Cannabinomimetics”. J. Biol. Chem. 281 (20), pp. 14192–14206. http://www.jbc.org/content/281/20/14192.full.pdf
^ Linde K, Barrett B, Wölkart K, Bauer R, Melchart D (Jan 2006). Linde, Klaus. ed. "Echinacea for preventing and treating the common cold". Cochrane Database Syst Rev (1): CD000530. doi:10.1002/14651858.CD000530.pub2. PMID 16437427.
^ a b "Product Review: Echinacea". ConsumerLab.com, LLC. 18 March 2004. Retrieved 2 August 2007.
^ Taylor JA, Weber W, Standish L, et al. (Dec 2003). "Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial" (Free full text). JAMA 290 (21): 2824–30. doi:10.1001/jama.290.21.2824. ISSN 0098-7484. PMID 14657066.
^ "Echinacea [NCCAM Herbs at a Glance"].
^ a b c Huntley AL, Thompson Coon J, Ernst E (2005). "The safety of herbal medicinal products derived from Echinacea species: a systematic review". Drug Saf 28 (5): 387–400. doi:10.2165/00002018-200528050-00003. ISSN 0114-5916. PMID 15853441.
^ Mullins RJ. Echinacea-associated anaphylaxis. Med J Aust 1998;168: 170-171
^ Ang-Lee MK, Moss J, Yuan CS (July 2001). "Herbal medicines and perioperative care". JAMA 286 (2): 208–16. doi:10.1001/jama.286.2.208. PMID 11448284.
^ a b "Echinacea (Echinacea angustifolia DC, Echinacea pallida, Echinacea purpurea): Safety - MayoClinic.com". Retrieved 2011-09-05.
^ Izzo AA, Ernst E (2009). "Interactions between herbal medicines and prescribed drugs: an updated systematic review". Drugs 69 (13): 1777–98. doi:10.2165/11317010-000000000-00000. PMID 19719333.
^ "A Comprehensive Echinacea Germplasm Collection Located at the North Central Regional Plant Introduction Station", USDA
^ Canlas J, Hudson JB, Sharma M, Nandan D.,"Echinacea and trypanasomatid parasite interactions: Growth-inhibitory and anti-inflammatory effects of Echinacea". Pharm Biol. 2010 Sep;48(9):1047-52
Mowrey, Daniel (1998). Echinacea. McGraw-Hill Professional. ISBN 9780879836108.
FONTE IMMAGINE: http://commons.wikimedia.org/wiki/File:Purple_coneflowers.jpgFONTE:
From Wikipedia, the free encyclopedia
Echinacea tennesseensis, also known as the Tennessee coneflower or Tennessee purple coneflower, is a flowering plant in the family Asteraceae, endemic to the cedar glades of the central portion of the U.S. state of Tennessee.
Echinacea tennesseensis is a herbaceous perennial plant growing to 75 centimetres (2.46 ft) tall. The leaves are hairy, lanceolate, and arranged in a basal whorl with only a few small leaves on the flower stems.
The flowers are produced in a capitulum (flowerhead) up to 8 cm broad, with a ring of purple ray florets surrounding the brown disc florets.
A noticeable characteristic is its generally erect ray flowers, in contrast to the more drooping rays of its most similar congener, E. angustifolia (widespread throughout the prairie of the central U.S.) and other common Echinacea species such as E. purpurea.
Echinacea tennesseensis is a federally listed endangered species, and is found in fewer than 10 locations in Davidson, Wilson, and Rutherford Counties.
It has been hypothesized that an ancestral Echinacea species spread into middle Tennessee during the hypsothermal period following the last ice age, when conditions were drier and prairies extended into much of the central eastern U.S. that is now forested. As conditions became wetter, the Echinacea populations became isolated on the prairie-like habitat of the cedar glades which were eventually surrounded by forest. This isolation resulted in divergence and speciation of E. tennesseensis.
The Tennessee coneflower was one of the federally listed endangered plant species and its recovery has been aided by the purchase of habitat by the Nature Conservancy and the State of Tennessee. The United States Fish and Wildlife Service has proposed that this plant be removed from the endangered species list because all the former threats to the species are eliminated or reduced. The Service ruled that the plant will be delisted effective September 2, 2011.
^ USFWS. Removing the Tennessee Purple Coneflower From the Federal List of Endangered and Threatened Plants. Federal Register August 12, 2010.
^ USFWS. Removal of Echinacea tennesseensis (Tennessee Purple Coneflower) From the Federal List of Endangered and Threatened Plants. Federal Register August 3, 2011.
Baskauf, C.J., D.E. McCauley, W.G. Eickmeier. (1994). Genetic analysis of a rare and a widespread species of Echinacea (Asteraceae), Evolution 48: 180-188 (abstract).
FONTE IMMAGINE: http://commons.wikimedia.org/wiki/File:Echinacea_pallida_var._tennesseensis.jpg